Skip to main content

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Investor Securities Class Action Lawsuit 07/19/2018

  • If you purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 3, 2022 - The court granted the defendants' motion to dismiss. May 31, 2021 - A motion to dismiss the third amended complaint was filed. April 16, 2021 - A third amended complaint was filed. March 29, 2021 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. August 28, 2020 - A motion to dismiss the second amended comp...



You must register (for free) or login to view the entire case.